A new system for fixing bone fractures, called the Bone Bolt System, has been approved for market by the U.S. Food and Drug Administration (FDA), the University of Utah Orthopaedic Innovation Center (OIC), Department of Orthopaedics and Spencer Fox Eccles School of Medicine announced on July 20, 2023.
SCHOTT Pharma shares to be offered within price range of EUR 24.50 to EUR 28.50 per share – Biotech Investments
EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): IPO SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma shares to be offered within price
September 19, 2023